Nuage Therapeutics
Nuage Therapeutics is a biotech company developing small-molecule inhibitors targeting oncogenic, lineage-specific transcription factors, aiming to address key cancer dependency genes with innovative therapeutic approaches.
About Nuage Therapeutics
Nuage Therapeutics is a biotechnology company founded in 2021 as a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA, created to translate breakthrough academic research into innovative medicines. The company was established to address challenging medical indications by developing drugs that target proteins with intrinsically disordered regions, a class of targets that has traditionally been difficult to drug. Since its founding, Nuage Therapeutics has focused on advancing novel therapeutic approaches aimed at delivering new treatment options for patients facing complex and unmet medical needs.
Recently Added Startups
Cresory
Cresory is a digital learning platform that teaches children finance through play, helping them understand money, saving, budgeting, and investing with fun, interactive e-learning experiences.
Bettermaps
Bettermaps creates beautiful, accurate, and unique digital maps by combining advanced cartography with intelligent technology, enabling users to generate customized maps quickly and easily for diverse use cases.
xpress delivery
Xpress Delivery is a B2B2C platform offering fast, same-day delivery within 2 hours, enabling businesses to reach customers instantly hassle-free, reliable, and efficient. Sell it, we deliver it.
Related Post
Business Ideas in Czech Republic
Top 10 Semiconductor Manufacturing Companies in Europe 2025
Bloq.it Funding News – Lisbon-Based Bloq.it Raises €28 Million In Series B Round
Biotech
Cocoon Bioscience
Cocoon Bioscience develops high-value enzymes and recombinant proteins using an automated platform that leverages cocooned insects as natural, low-cost bioreactors, providing efficient, sustainable, and scalable solutions for biotechnology applications.
TOLREMO therapeutics
TOLREMO Therapeutics is a Swiss biotech company dedicated to preventing non-genetic cancer drug resistance by targeting early defense mechanisms and key transcriptional pathways to improve the effectiveness of targeted therapies.
Spain
Cocoon Bioscience
Cocoon Bioscience develops high-value enzymes and recombinant proteins using an automated platform that leverages cocooned insects as natural, low-cost bioreactors, providing efficient, sustainable, and scalable solutions for biotechnology applications.
Nuage Therapeutics
Nuage Therapeutics is a biotech company developing small-molecule inhibitors targeting oncogenic, lineage-specific transcription factors, aiming to address key cancer dependency genes with innovative therapeutic approaches.